[1]Mbeunkui F,Johann DJ,Jr. Cancer and the tumor microenvironment:A review of an essential relationship[J].Cancer Chemother Pharmacol,2009,63(4):571582.
[2]张淑萍.中药治疗原发性肝癌术后化疗副反应50例[J].环球中医药,2009,2(5):340342.
[3]Huang GC,Chen LB. Tumor vasculature and microenvironment normalization:Apossible mechanism of antiangiogenesis therapy[J].Cancer Biother Radiopharm,2008,23(5):661667.
[4]Liotta LA,Kohn EC. The microenvironment of the tumourhost interface[J].Nature,2001,411(6835):375379.
[5]Joyce JA,Pollard JW. Microenvironmental regulation of metastasis[J].Nat Rev Cancer,2009,9(4):239252.
[6]邱斌玉,温浩,张金辉.肝癌复发转移微环境研究进展[J].肝胆外科杂志,2010,18(1):6266.
[7]Gupta GP,Massaque J. Cancermetastasis:building a framework[J].Cell,2006,127(4):679695.
[8]丰俊东,林代华.刺五加皂苷对血管内皮生长因子表达的抑制作用[J].中华中医药学刊,2008,26(3):661662.
[9]Bangoura G,Liu Z S,Qian Q,et al. Prognostic significance of HIF2alpha/EPAS1 expression in hepatocellular carcinoma[J].World J Gastroenterol,2007,13(23):31763182.
[10]Rosmorduc O,Housset C. Hypoxia:a link between fibrogenesis,angiogenesis,and carcinogenesis in liver disease [J].Semin L iver Dis,2010,30(3):258270.
[11]王照红,王志明.肝细胞癌缺氧微环境下PHD2的表达及其与血管生成的关系[J].中国普通外科杂志,2010,19(10):11131117.
[12]奚胜艳,高学敏,张建军,等.从中医络病与病络理论认识肿瘤血管生成[J].北京中医药大学学报,2008,31(12):804807.
[13]符寒,和水祥,徐俊丽,等.丹参酮IIA对肝癌细胞血管内皮生长因子表达的影响[J].西安交通大学学报(医学版),2009,30(1):115118.
[14]丁志山,高承贤,陈铌铍,等.姜黄素具有抑制血管生成与诱导肿瘤细胞凋亡双重作用[J].中国药理学通报,2003,19(2):171173.
[15]常远鸿,江梅,刘凯歌.姜黄素对缺氧诱导肝癌细胞HepG2上皮细胞间质转分化(EMT)的逆转作用[J].现代肿瘤医学,2012,20(9):17631767.
[16]丰俊东,林代华.刺五加皂苷对血管内皮生长因子表达的抑制作用[J].中华中医药学刊,2008,26(3):661662.
[17]王生,赵杨,陶丽,等.靶向纤溶系统活血化瘀药的抗肿瘤活性研究进展[J].中草药,2012,43(6):12131218.
[18]蒋跃绒,陈可冀.川芎嗪的心脑血管药理作用及临床应用研究进展[J].中国中西医结合杂志,2013,33(5):707711.
[19]蒋跃绒,殷惠军,陈可冀.赤芍801研究现状[J].中国中西医结合杂志,2004,24(8):760763.
[20]钱彦方.活血化瘀中药对肿瘤形成和转移的影响[J].中医杂志,2008,49(10):942945.